View of Computational analysis on FR258900 as dual-target inhibitor of bace-1 and acetylcholinesterase in treatment of Alzheimer's disease: A combined molecular docking and ADMET study

Return to Article Details Computational analysis on FR258900 as dual-target inhibitor of bace-1 and acetylcholinesterase in treatment of Alzheimer's disease: A combined molecular docking and ADMET study Download Download PDF